• 1
    Conley ME, Delacroix DL. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann Intern Med 1987; 106: 8929.
  • 2
    Mestecky J, Russell MW. Iga subclasses. Monogr Allergy 1986; 19: 277301.
  • 3
    Kett K, Brandtzaeg P, Radl J, Haaijman JJ. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol 1986; 136: 36315.
  • 4
    Delacroix DL, Dive C, Rambaud JC, Vaerman JP. IgA subclasses in various secretions and in serum. Immunology 1982; 47: 3835.
  • 5
    Brown TA, Mestecky J. Immunoglobulin A subclass distribution of naturally occurring salivary antibodies to microbial antigens. Infect Immun 1985; 49: 45962.
  • 6
    Ladjeva I, Peterman JH, Mestecky J. IgA subclasses of human colostral antibodies specific for microbial and food antigens. Clin Exp Immunol 1989; 78: 8590.
  • 7
    Kilian M, Reinholdt J. A hypothetical model for the development of invasive infection due to IgA1 protease-producing bacteria. Adv Exp Med Biol 1987; 9: 12619.
  • 8
    Moldoveanu Z, Brown TA, Ventura MT, Michalek SM, McGhee JR, Mestecky J. IgA subclass responses to lipopolysaccharide in humans. Adv Exp Med Biol 1987; 205: 1199205.
  • 9
    Hammarstrom L, Persson MA, Smith CI. Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors. Immunology 1985; 54: 8216.
  • 10
    Korkeila M, Lehtonen H, Ahman H, Leroy O, Eskola J, Kayhty H. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Vaccine 2000; 18: 121826.
  • 11
    Nurkka A, Lahdenkari M, Palmu AA, Kayhty H, the Finom Study Group. Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial. BMC Infect Dis 2005; 5: 41.
  • 12
    Syrjanen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J Infect Dis 2001; 184: 4519.
  • 13
    Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001; 20: 65462.
  • 14
    Rapola S, Jantti V, Haikala R et al. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis 2000; 182: 114652.
  • 15
    Soininen A, Pursiainen H, Kilpi T, Kayhty H. Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children. J Infect Dis 2001; 184: 56976.
  • 16
    Simell B, Korkeila M, Pursiainen H, Kilpi TM, Kayhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children. J Infect Dis 2001; 183: 88796.
  • 17
    Simell B, Kilpi TM, Käyhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J Infect Dis 2002; 186: 110614.
  • 18
    Adrian PV, Bogaert D, Oprins M et al. Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media. Vaccine 2004; 22: 273742.
  • 19
    Coughlin RT, White AC, Anderson CA, Carlone GM, Klein DL, Treanor J. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine 1998; 16: 17617.
  • 20
    Yu X, Sun Y, Frasch C, Concepcion C, Nahm MH. Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic. Clin Diagn Lab Immunol 1999; 6: 51924.
  • 21
    Soininen A, Van Den Dobbelsteen G, Oomen L, Kayhty H. Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific? Clin Diagn Lab Immunol 2000; 7: 46876.
  • 22
    Concepcion NF, Frasch CE. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2001; 8: 26672.
  • 23
    Gray BM, Converse GM III, Dillon HC Jr. Serotypes of Streptococcus pneumoniae causing disease. J Infect Dis 1979; 140: 97983.
  • 24
    Gray BM, Converse GM III, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980; 142: 92333.
  • 25
    McAllister LJ, Tseng HJ, Ogunniyi AD, Jennings MP, McEwan AG, Paton JC. Molecular analysis of the psa permease complex of Streptococcus pneumoniae. Mol Microbiol 2004; 53: 889901.
  • 26
    Rapola S, Kilpi T, Lahdenkari M, Takala AK, Makela PH, Kayhty H. Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media? J Infect Dis 2001; 184: 57781.
  • 27
    Rapola S, Kilpi T, Lahdenkari M, Makela PH, Kayhty H. Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media. Pediatr Infect Dis J 2001; 20: 4827.
  • 28
    Rapola S, Jantti V, Eerola M, Makela PH, Kayhty H, Kilpi T. Anti-PsaA and the risk of pneumococcal AOM and carriage. Vaccine 2003; 21: 360813.
  • 29
    Pilling PA, Lawrence MC, Berry AM, Ogunniyi AD, Lock RA, Paton JC. Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae. Acta Crystallogr D Biol Crystallogr 1998; 54: 14646.
  • 30
    Russel MW, Lue C, Van Den Wall Bake AWL, Moldoveanu Z, Mestecky J. Molecular heterogeneity of human IgA antibodies during an immune response. Clin Exp Immunol 1992; 87: 16.
  • 31
    Crago SS, Kutteh WH, Moro I et al. Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol 1984; 132: 1618.
  • 32
    Kutteh WH, Hatch KD, Blackwell RE, Mestecky J. Secretory immune system of the female reproductive tract. I. Immunoglobulin and secretory component-containing cells. Obstet Gynecol 1988; 71: 5660.
  • 33
    Ahl T, Reinholdt J. Subclass distribution of salivary secretory immunoglobulin A antibodies to oral streptococci. Infect Immun 1991; 59: 361925.
  • 34
    Smith DJ, King WF, Taubman MA. Isotype, subclass and molecular size of immunoglobulins in salivas from young infants. Clin Exp Immunol 1989; 76: 97102.
  • 35
    Kilian M, Reinholdt J, Mortensen SB, Sorensen CH. Perturbation of mucosal immune defence mechanisms by bacterial IgA proteases. Bull Eur Physiopathol Respir 1983; 19: 99104.
  • 36
    Weiser JN, Bae D, Fasching C, Scamurra RW, Ratner AJ, Janoff EN. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci USA 2003; 100: 421520.
  • 37
    Tappuni AR, Challacombe SJ. A comparison of salivary immunoglobulin A (IgA) and IgA subclass concentrations in predentate and dentate children and adults. Oral Microbiol Immunol 1994; 9: 1425.
  • 38
    Fitzsimmons SP, Evans MK, Pearce CL, Sheridan MJ, Wientzen R, Cole MF. Immunoglobulin A subclasses in infants’ saliva and in saliva and milk from their mothers. J Pediatr 1994; 124: 56673.
  • 39
    Cole MF, Evans MK, Fitzsimmons SP et al. Pioneer oral streptococci produce immunoglobulin A1 protease. Infect Immun 1994; 62: 21658.
  • 40
    Kauppi-Korkeila M, Saarinen L, Eskola J, Kayhty H. Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines. Clin Exp Immunol 1998; 111: 23742.
  • 41
    Choo S, Zhang Q, Seymour L, Akhtar S, Finn A. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants. J Infect Dis 2000; 182: 12603.
  • 42
    Nurkka A, Ahman H, Yaich M, Eskola J, Kayhty H. Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT. Vaccine 2001; 20: 194201.
  • 43
    Nurkka A, Ahman H, Korkeila M, Jantti V, Kayhty H, Eskola J. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001; 20: 2533.